Tadahiro Shoji (Shoji Tadahiro)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Endometrial Cancer

Top Venues

Healthcare (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, Masahiro Kagabu, Dai Shimizu, Tatsuhiko Shigeto, Tsukasa Baba, Toru Sugiyama, Yoshihito Yokoyama
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study). Cancers 15 (21) (2023)
Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, Tatsuhiko Shigeto, Yukiko Matsumura, Dai Shimizu, Yukihiro Terada, Manabu Seino, Tsuyoshi Ohta, Satoru Nagase, Shogo Shigeta, Hideki Tokunaga, Muneaki Shimada, Michiko Kaiho-Sakuma, Shigenori Furukawa, Shu Soeda, Takafumi Watanabe, Fumiaki Takahashi, Yoshihito Yokoyama
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study). International journal of clinical oncology 27 (12) (2022)
Tomomi Egawa-Takata, Yutaka Ueda, Kimihiko Ito, Kensuke Hori, Tadahiro Shoji, Takayuki Nagasawa, Shin Nishio, Kimio Ushijma, Nishino Koji, Takayuki Enomoto, Akira Kikuchi, Shigeru Honma, Tetsuro Ohishi, Muneaki Shimada, Yuji Takei, Hiroyuki Fujiwara, Hiroshi Tanabe, Aikou Okamoto, Yukihiro Nishio, Tomomi Yamada, Tadashi Kimura
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma. Cancer science 113 (5) (2022)
Tadahiro Shoji, Chie Sato, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer. Medicina (Kaunas, Lithuania) 57 (5) (2021)
Tadahiro Shoji, Takayuki Enomoto, Masakazu Abe, Aikou Okamoto, Takayuki Nagasawa, Tetsuro Oishi, Satoru Nagase, Masahiko Mori, Yuki Inokuchi, Shoji Kamiura, Shinichi Komiyama, Nobuhiro Takeshima, Toru Sugiyama
Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023. Cancer science (2021)
Tadahiro Shoji, Shunsuke Tatsuki, Marina Abe, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, Hiroaki Itamochi
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas. Cancers 13 (23) (2021)
Masahiro Kagabu, Takayuki Nagasawa, Shunsuke Tatsuki, Yasuko Fukagawa, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Tadahiro Shoji, Tsukasa Baba
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study. Medicina (Kaunas, Lithuania) 57 (6) (2021)
Masahiro Kagabu, Takayuki Nagasawa, Chie Sato, Yasuko Fukagawa, Hanae Kawamura, Hidetoshi Tomabechi, Shuji Takemoto, Tadahiro Shoji, Tsukasa Baba
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions. International journal of molecular sciences 21 (7) (2020)
Masahiro Kagabu, Takayuki Nagasawa, Daisuke Fukagawa, Hidetoshi Tomabechi, Saiya Sato, Tadahiro Shoji, Tsukasa Baba
Immunotherapy for Uterine Cervical Cancer. Healthcare (Basel, Switzerland) 7 (3) (2019)
Tadahiro Shoji, Hisashi Eto, Takanori Sato, Rikako Soma, Daisuke Fukagawa, Hidetoshi Tomabechi, Eriko Takatori, Takayuki Nagasawa, Seiya Sato, Masahiro Kagabu, Tsukasa Baba
A New Therapeutic Strategy for Recurrent Ovarian Cancer-Bevacizumab beyond Progressive Disease. Healthcare (Basel, Switzerland) 7 (3) (2019)